Sii

Adar Poonawalla warns against return to business-as-usual approach

He pointed out that there is rising vaccine fatigue among the public as the main reason for the low off-take of the vaccines even after the firm has massively slashed the price from Rs 600 to Rs 225 a dose

COVID-19 vaccine: In a 'philanthropic gesture', SII reduces Covishield price to Rs 300 per dose for states

This follows widespread criticism of the pricing policy of the SII, which sold the initial doses of Covishield to the Central Government at Rs 150 per dose

Serum Institute CEO Adar Poonawalla urges Novak Djokovic to get vaccinated, tweet goes viral

World number one tennis player Novak Djokovic was barred from participating in the Australian Open as he refused to get vaccinated against coronavirus

Serum Institute pledges over $66 million to Oxford University for vaccine research centre

The main focus of the research taking place in the Poonawalla Building will be vaccinology and it will house over 300 research scientists

India pulled back vaccine supply to COVAX due to surge of cases inside country, says USAID administrator

The shortage is going to end soon as the US has purchased the Pfizer vaccine, which will start to come online in August, Samantha Power told a Congressional Committee

Serum Institute of India to start manufacturing Sputnik V in September, says RDIF

As per the agreement between the Russian Direct Investment Fund and Serum Institute, the parties intend to produce over 300 million doses of the vaccine in India per year

COVID-19: WHO chief asks countries to vaccinate 10% of population by Sept; why rapid vaccination is crucial

According to a UN report, COVID-19 vaccination rates are uneven across countries, ranging from below 1% of the population in some countries to above 60% in others

SII may roll out Novavax's Covovax COVID-19 vaccine by Sept; key updates on India's vaccine drive

Novavax said that the efficacy of its vaccine was 93.2 percent against Variants of Concern (VoC) and Variants of Interest (VoI), which represented 82 percent of the cases during trials

Covishield dose gap row: Harsh Vardhan says decision was taken unanimously; calls controversy 'unfortunate'

Covishield dose gap row: Union health minister Harsh Vardhan too said the decision to increase the gap “has been taken in a transparent manner based on scientific data”

Russia only country in world ready to transfer anti-COVID vaccine technology, says Vladimir Putin

The Russian president made the remarks during a virtual interaction with senior editors of international news agencies and rejected concerns over Sputnik V's efficacy